Navigation Links
HPV eradicated by AHCC supplement, preclinical study suggests
Date:3/23/2014

(March 23, 2014, Beaverton, OR) Treating cervical cancer cells with AHCC led to the eradication of HPV, human papillomavirus, as well as a decrease in the rate of tumor growth in-vitro and in-vivo, in research presented at the Society of Gynecological Oncology 45th Annual Meeting on Women's Cancer in Tampa, Florida. The study was led by Dr. Judith A. Smith, Pharm.D., at the University of Texas Health Science Center (UTHealth) Medical School at Houston.

In the study cervical cancer cells were treated with AHCC and incubated for 72 hours with sampling every 24 hours. The study was then repeated in two orthotopic mouse models, one HPV positive and other HPV negative control. The HPV expression was eradicated with once daily AHCC dosing for 90 days with durable response after 30 day observation off treatment. Dr. Smith then repeated the study to confirm findings and added sampling for correlative testing of immune markers to determine the mechanism by which AHCC eradicates the HPV virus.

These data suggest AHCC can eliminate HPV infections and may have a role in the prevention of HPV-related cancers. A confirmatory pilot study in HPV+ women is underway at UTHealth Women's Center.

"The results of this study were very encouraging," said Dr. Smith, Associate Professor at the UTHealth Medical School. "This study, initiated in 2008, shows that by itself AHCC has the potential to treat the HPV infection," she said. Smith's previous study evaluated AHCC integration with common chemotherapy agents used for the treatment of ovarian cancer, to screen for potential drug interactions and improvement in activity.

AHCC works as an immunotherapy, which is a treatment that uses a body's own immune system to help fight disease. Human and in-vivo studies have shown that AHCC increases the number and/or activity of Natural Killer (NK) cells, dendritic c
'/>"/>

Contact: John Carney or Julie McQuain
JMPRmedia@aol.com
212-477-0472
JMPR Associates, Inc.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New L-Carnitine and Green Coffee Bean Supplement, L-Carnitine Plus Now Available
2. Nutralife Health Products Inc. Announces Launch of New Website for its Revolutionary Joint Supplement, JointRite
3. Successful Dieter Starts Gold Coast With Revolutionary Weight Loss Supplement, Garcinia Cambogia
4. PhenObestin 37.5, a Pharmaceutical Grade Dietary Supplement, Urges Dieters to Lose Weight Without Experiencing Harmful Side Effects
5. LifeBotanica's Groundbreaking Anti-Aging Supplement, AGE DEFYING, Introduced
6. HyperGH 14x, the Natural Supplement, is Finally Available at NaturalHerbalz.net to Boost Muscle Growth Naturally and Safely
7. Preclinical data support ongoing clinical trials testing IDO inhibitors as a treatment for cancer
8. Genetically-engineered preclinical models predict pharmacodynamic response
9. Preclinical study identifies master proto-oncogene that regulates ovarian cancer metastasis
10. Preclinical tests shows agent stops slippery proteins from binding, causing Ewing sarcoma
11. Mayo Clinic: Preclinical tests may lead to new approach to treat CNS lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015 The panel of independent experts ... 98 candidates short-listed for the awards presented tonight at ... was fierce but the best-of-the-best can now be revealed ... Group , Volvo swept rivals aside by taking the ... unanimous praise from our panel of expert judges., Stand ...
(Date:6/3/2015)... PA (PRWEB) June 03, 2015 Sitting ... can cause discomfort in the back, neck, shoulders and/or ... other musculoskeletal injuries. In addition, recent research links sitting ... number of chronic diseases. Fortunately, three inventors from Oakville, ... sit at a desk. , They have developed a ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Acne is ... (“bacne”) can be particularly stubborn to eliminate and hard to ... most common in teens and young adults, in the years ... produce sebum, or oil,” says Jayme Bashian, director and lead ... characteristic pimples, blackheads and cysts of acne are caused by ...
(Date:6/3/2015)... These are challenging and unpredictable times for traditional organizations ... business are rewriting the rules for business as we ... traditional businesses to take on a more agile approach ... On top of this there is a growing ... bring new innovation and approaches to business. , The ...
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch as ... latest and coolest technology products available to consumers. Andrew ... conducted the review and shared with viewers how this ... stores. , Tracking statistics in business is invaluable in ... retail this goes a step beyond revenue statistics and ...
Breaking Medicine News(10 mins):Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2
... benefits of short-term use of hormone therapy in menopausal women ... of life, but they may also shorten their life expectancy ... not to use hormone therapy can be a difficult decision. ... but are the risks worth the benefits? Question researchers . ...
... awareness is needed about the risks of certain prescribed drugs ... // multiple chronic conditions and take several drugs concurrently many ... ,Researchers conducted a study to look at medication prescriptions ... more than 20 percent of the people filled a prescription ...
... with hemophilia arthropathy, a severe form of hemophilia that ... // than other children for developing osteoporosis in ... in preventing osteoporosis from hitting these children, say researchers. ... activities than was previously advised by doctors. An exercise ...
... a tracheoesophageal puncture (TEP), is an incision between the ... small plastic //or silicone valve , researchers say this ... and neck cancer patients who have had their voice ... combined with post operative speech rehabilitation therapy, can provide ...
... have now found a way to genetically engineer the common ... healthy ones intact.// They did this by modifying one gene, ... had to boost the activity of another gene to ensure ... say, “When the virus infects cells, it takes the altered ...
... get a prescription for a potentially lifesaving drug after ... which the heart has trouble pumping blood. // ... who don’t receive an angiotensin-converting enzyme inhibitor are 14-percent ... who do get the drug. ACE inhibitors work by ...
Cached Medicine News:
(Date:6/3/2015)...  (AHIP Institute Booth 1021) --  Availity , the ... a wide range of information to help health plans ... Health Insurance Plan,s (AHIP,s) 2015 Institute , June 3-5, ... Availity released a special report to AHIP Institute ... opportunities." The report identifies billions of dollars ...
(Date:6/3/2015)... MARLBOROUGH, Mass. , June 3, 2015 ... RXII ), a biotechnology company focused on ... the areas of dermatology and ophthalmology, today announced ... from the United States Patent and Trademark ... platform (sd‑rxRNA®). The patent, titled "RNA Interference ...
(Date:6/3/2015)... 3, 2015  EIP Pharma LLC ( www.eippharma.com ) ... development of VX-745 in Alzheimer,s disease (AD) is underway.  ... potent inhibitor of the alpha isoform of the protein ... "Recent human genetic data demonstrate that inflammation ... symptomatic Alzheimer,s, while the science also indicates the p38 ...
Breaking Medicine Technology:Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 2RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 4EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or ... related services, today announced that it received a letter ... Amex of the "record date" for the 2012 Annual ... the record date for the Company,s 2012 Annual Meeting, ...
... (NASDAQ: ROCM ) is pleased to announce an addition ... of the Magic3 Hydrophilic Intermittent Catheter with Coude Tip ... very latest Magic3 technology. It provides the ... designed curved tip configuration. The Coude tip is ...
Cached Medicine Technology:InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders 2Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter 2
4 mm x 9 mm tip....
Large. Double-ended. 3 mm pointed end and 5 mm angled end....
4 mm wide tip....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Medicine Products: